These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 16001973)

  • 1. Response rate of fibrosarcoma cells to cytotoxic drugs on the expression level correlates to the therapeutic response rate of fibrosarcomas and is mediated by regulation of apoptotic pathways.
    Lehnhardt M; Klein-Hitpass L; Kuhnen C; Homann HH; Daigeler A; Steinau HU; Roehrs S; Schnoor L; Steinstraesser L; Mueller O
    BMC Cancer; 2005 Jul; 5():74. PubMed ID: 16001973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pro‑apoptotic effects of pycnogenol on HT1080 human fibrosarcoma cells.
    Harati K; Slodnik P; Chromik AM; Behr B; Goertz O; Hirsch T; Kapalschinski N; Klein-Hitpass L; Kolbenschlag J; Uhl W; Lehnhardt M; Daigeler A
    Int J Oncol; 2015 Apr; 46(4):1629-36. PubMed ID: 25625225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resveratrol induces apoptosis and alters gene expression in human fibrosarcoma cells.
    Harati K; Slodnik P; Chromik AM; Goertz O; Hirsch T; Kapalschinski N; Klein-Hitpass L; Kolbenschlag J; Uhl W; Lehnhardt M; Daigeler A
    Anticancer Res; 2015 Feb; 35(2):767-74. PubMed ID: 25667456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-197-5p increases Doxorubicin-mediated anticancer cytotoxicity of HT1080 fibrosarcoma cells by decreasing drug efflux.
    Jain N; Das B; Mallick B
    DNA Repair (Amst); 2022 Jan; 109():103259. PubMed ID: 34871862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imatinib inhibits proliferation of Ewing tumor cells mediated by the stem cell factor/KIT receptor pathway, and sensitizes cells to vincristine and doxorubicin-induced apoptosis.
    González I; Andreu EJ; Panizo A; Inogés S; Fontalba A; Fernández-Luna JL; Gaboli M; Sierrasesúmaga L; Martín-Algarra S; Pardo J; Prósper F; de Alava E
    Clin Cancer Res; 2004 Jan; 10(2):751-61. PubMed ID: 14760098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant TIMP-1-GPI inhibits growth of fibrosarcoma and enhances tumor sensitivity to doxorubicin.
    Bao Q; Niess H; Djafarzadeh R; Zhao Y; Schwarz B; Angele MK; Jauch KW; Nelson PJ; Bruns CJ
    Target Oncol; 2014 Sep; 9(3):251-61. PubMed ID: 23934106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of cyclin D1 overexpression on drug sensitivity in a human fibrosarcoma cell line.
    Hochhauser D; Schnieders B; Ercikan-Abali E; Gorlick R; Muise-Helmericks R; Li WW; Fan J; Banerjee D; Bertino JR
    J Natl Cancer Inst; 1996 Sep; 88(18):1269-75. PubMed ID: 8797766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combinatorial effects of doxorubicin and retargeted tissue factor by intratumoral entrapment of doxorubicin and proapoptotic increase of tumor vascular infarction.
    Stucke-Ring J; Ronnacker J; Brand C; Höltke C; Schliemann C; Kessler T; Schmidt LH; Harrach S; Mantke V; Hintelmann H; Hartmann W; Wardelmann E; Lenz G; Wünsch B; Müller-Tidow C; Mesters RM; Schwöppe C; Berdel WE
    Oncotarget; 2016 Dec; 7(50):82458-82472. PubMed ID: 27738341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversal of multidrug resistance by transduction of cytokine genes into human colon carcinoma cells.
    Stein U; Walther W; Shoemaker RH
    J Natl Cancer Inst; 1996 Oct; 88(19):1383-92. PubMed ID: 8827016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrinsic resistance to chemotherapeutic agents in murine osteosarcoma cells.
    Takeshita H; Kusuzaki K; Ashihara T; Gebhardt MC; Mankin HJ; Hirasawa Y
    J Bone Joint Surg Am; 2000 Jul; 82-A(7):963-9. PubMed ID: 10901311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The time-dependent serial gene response to Zeocin treatment involves caspase-dependent apoptosis in HeLa cells.
    Hwang J; Kim YY; Huh S; Shim J; Park C; Kimm K; Choi DK; Park TK; Kim S
    Microbiol Immunol; 2005; 49(4):331-42. PubMed ID: 15840958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TRAIL and doxorubicin combination induces proapoptotic and antiangiogenic effects in soft tissue sarcoma in vivo.
    Wang S; Ren W; Liu J; Lahat G; Torres K; Lopez G; Lazar AJ; Hayes-Jordan A; Liu K; Bankson J; Hazle JD; Lev D
    Clin Cancer Res; 2010 May; 16(9):2591-604. PubMed ID: 20406839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyaluronidase induces murine L929 fibrosarcoma cells resistant to tumor necrosis factor and Fas cytotoxicity in the presence of actinomycin D.
    Chang NS
    Cell Biochem Biophys; 1995-1996; 27(2):109-32. PubMed ID: 9106395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TRAIL and Taurolidine induce apoptosis and decrease proliferation in human fibrosarcoma.
    Daigeler A; Brenzel C; Bulut D; Geisler A; Hilgert C; Lehnhardt M; Steinau HU; Flier A; Steinstraesser L; Klein-Hitpass L; Mittelkötter U; Uhl W; Chromik AM
    J Exp Clin Cancer Res; 2008 Dec; 27(1):82. PubMed ID: 19077262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zoledronic acid inhibits proliferation of human fibrosarcoma cells with induction of apoptosis, and shows combined effects with other anticancer agents.
    Koto K; Murata H; Kimura S; Horie N; Matsui T; Nishigaki Y; Ryu K; Sakabe T; Itoi M; Ashihara E; Maekawa T; Fushiki S; Kubo T
    Oncol Rep; 2010 Jul; 24(1):233-9. PubMed ID: 20514467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast cancer cells response to the antineoplastic agents cisplatin, carboplatin, and doxorubicin at the mRNA expression levels of distinct apoptosis-related genes, including the new member, BCL2L12.
    Thomadaki H; Scorilas A
    Ann N Y Acad Sci; 2007 Jan; 1095():35-44. PubMed ID: 17404015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TRAIL and taurolidine enhance the anticancer activity of doxorubicin, trabectedin and mafosfamide in HT1080 human fibrosarcoma cells.
    Harati K; Chromik AM; Bulut D; Goertz O; Hahn S; Hirsch T; Klein-Hitpass L; Lehnhardt M; Uhl W; Daigeler A
    Anticancer Res; 2012 Jul; 32(7):2967-84. PubMed ID: 22753761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Actinomycin D synergistically enhances the efficacy of the BH3 mimetic ABT-737 by downregulating Mcl-1 expression.
    Olberding KE; Wang X; Zhu Y; Pan J; Rai SN; Li C
    Cancer Biol Ther; 2010 Nov; 10(9):918-29. PubMed ID: 20818182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel antisense oligonucleotide inhibiting several antiapoptotic Bcl-2 family members induces apoptosis and enhances chemosensitivity in androgen-independent human prostate cancer PC3 cells.
    Yamanaka K; Rocchi P; Miyake H; Fazli L; Vessella B; Zangemeister-Wittke U; Gleave ME
    Mol Cancer Ther; 2005 Nov; 4(11):1689-98. PubMed ID: 16275990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NUPR1 interacts with p53, transcriptionally regulates p21 and rescues breast epithelial cells from doxorubicin-induced genotoxic stress.
    Clark DW; Mitra A; Fillmore RA; Jiang WG; Samant RS; Fodstad O; Shevde LA
    Curr Cancer Drug Targets; 2008 Aug; 8(5):421-30. PubMed ID: 18690848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.